These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31088060)

  • 41. Versatile synthetic strategies for PBCA-based hybrid fluorescent microbubbles and their potential theranostic applications to cell labelling and imaging.
    Liu Z; Koczera P; Doleschel D; Kiessling F; Gätjens J
    Chem Commun (Camb); 2012 May; 48(42):5142-4. PubMed ID: 22516972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of 18F-labeled targeted perfluorocarbon-filled albumin microbubbles as a probe for microUS and microPET in tumor-bearing mice.
    Liao AH; Wu SY; Wang HE; Weng CH; Wu MF; Li PC
    Ultrasonics; 2013 Feb; 53(2):320-7. PubMed ID: 22832082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
    Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interventional Nanotheranostics: Advancing Nanotechnology Applications with IR.
    Matsumoto MM; Kim DH; Larson AC; Mouli SK
    J Vasc Interv Radiol; 2019 Nov; 30(11):1824-1829.e1. PubMed ID: 31655765
    [No Abstract]   [Full Text] [Related]  

  • 45. Investigation of polymer-shelled microbubble motions in acoustophoresis.
    Kothapalli SV; Wiklund M; Janerot-Sjoberg B; Paradossi G; Grishenkov D
    Ultrasonics; 2016 Aug; 70():275-83. PubMed ID: 27261567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
    Tinkov S; Winter G; Coester C; Bekeredjian R
    J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles.
    Azmin M; Harfield C; Ahmad Z; Edirisinghe M; Stride E
    Curr Pharm Des; 2012; 18(15):2118-34. PubMed ID: 22352768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrasound assessment of polymer-shelled magnetic microbubbles used as dual contrast agents.
    Sciallero C; Trucco A
    J Acoust Soc Am; 2013 Jun; 133(6):EL478-84. PubMed ID: 23742443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
    Mosayebi J; Kiyasatfar M; Laurent S
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial Activity and Biosensing of PVA-Lysozyme Microbubbles Formed by Pressurized Gyration.
    Mahalingam S; Xu Z; Edirisinghe M
    Langmuir; 2015 Sep; 31(36):9771-80. PubMed ID: 26307462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review on the role of lipid-based nanoparticles in medical diagnosis and imaging.
    Mirahadi M; Ghanbarzadeh S; Ghorbani M; Gholizadeh A; Hamishehkar H
    Ther Deliv; 2018 Aug; 9(8):557-569. PubMed ID: 30071803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Relevance of contrast ultrasound with microbubbles in vascular medecine].
    Erdmann A; Ney B; Alatri A; Calanca L; Mazzolai L
    Rev Med Suisse; 2016 Dec; 12(542):2131-2134. PubMed ID: 28700167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals.
    Schutt EG; Klein DH; Mattrey RM; Riess JG
    Angew Chem Int Ed Engl; 2003 Jul; 42(28):3218-35. PubMed ID: 12876730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
    Unnikrishnan S; Klibanov AL
    AJR Am J Roentgenol; 2012 Aug; 199(2):292-9. PubMed ID: 22826389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy.
    Zhao T; Qin S; Peng L; Li P; Feng T; Wan J; Yuan P; Zhang L
    Carbohydr Polym; 2019 Jun; 214():221-233. PubMed ID: 30925992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response of contrast agents to ultrasound.
    Sboros V
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1117-36. PubMed ID: 18486270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative guidelines for the prediction of ultrasound contrast agent destruction during injection.
    Threlfall G; Wu HJ; Li K; Aldham B; Scoble J; Sutalo ID; Raicevic A; Pontes-Braz L; Lee B; Schneider-Kolsky M; Ooi A; Coia G; Manasseh R
    Ultrasound Med Biol; 2013 Oct; 39(10):1838-47. PubMed ID: 23849383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of contrast agent destruction.
    Chomas JE; Dayton P; Allen J; Morgan K; Ferrara KW
    IEEE Trans Ultrason Ferroelectr Freq Control; 2001 Jan; 48(1):232-48. PubMed ID: 11367791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted microbubbles in the experimental and clinical setting.
    Alzaraa A; Gravante G; Chung WY; Al-Leswas D; Bruno M; Dennison AR; Lloyd DM
    Am J Surg; 2012 Sep; 204(3):355-66. PubMed ID: 22920405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbubbles and ultrasound: from diagnosis to therapy.
    Dijkmans PA; Juffermans LJ; Musters RJ; van Wamel A; ten Cate FJ; van Gilst W; Visser CA; de Jong N; Kamp O
    Eur J Echocardiogr; 2004 Aug; 5(4):245-56. PubMed ID: 15219539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.